Related references
Note: Only part of the references are listed.A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis
Gaurav Sharma et al.
AUTOPHAGY (2019)
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST
Milena Urbini et al.
GENES CHROMOSOMES & CANCER (2019)
Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research
Josephine T. Tauer et al.
JBMR PLUS (2019)
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
Daniela Gasparotto et al.
CLINICAL CANCER RESEARCH (2017)
Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Maria A. Pantaleo et al.
MOLECULAR CANCER RESEARCH (2017)
The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
Alex Kim et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST
Monica Brenca et al.
JOURNAL OF PATHOLOGY (2016)
FGFR1 and NTRK3 actionable alterations in Wild-Type gastrointestinal stromal tumors
Eileen Shi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case
Martin G. Belinsky et al.
BMC CANCER (2015)
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
Maria A. Pantaleo et al.
CANCER MEDICINE (2015)
Prognostic and predictive biomarkers in lung cancer. A review
Erik Thunnissen et al.
VIRCHOWS ARCHIV (2014)
Expression of the Receptor for Type I Insulin-like Growth Factor (IGF1R) in Gastrointestinal Stromal Tumors An Immunohistochemical Study of 1078 Cases With Diagnostic and Therapeutic Implications
Jerzy Lasota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST)
Margherita Nannini et al.
JOURNAL OF MEDICAL GENETICS (2013)
Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy
Nicola Rath et al.
EMBO REPORTS (2012)
Gastrointestinal stromal tumours - an update for histopathologists
Newton A. C. S. Wong
HISTOPATHOLOGY (2011)
Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis
Zhi Hong Lu et al.
CANCER RESEARCH (2010)
Testing for CHEK2 in the cancer genetics clinic: ready for prime time?
S. A. Narod
CLINICAL GENETICS (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
Michael C. Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Share Paper
